Biotricity, Inc.
BTCY
$0.50
-$0.02-3.85%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 26.85% | 24.83% | 16.88% | 24.46% | 25.58% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | 9.43% | 39.40% | 120.73% | 192.25% | 259.32% |
| Total Other Non-Cash Items | -10.09% | 27.21% | 31.33% | -25.01% | -31.10% |
| Change in Net Operating Assets | 9.88% | -7.67% | 0.65% | 59.52% | 42,077.92% |
| Cash from Operations | 57.53% | 52.98% | 43.95% | 50.59% | 54.91% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -55.02% | -74.34% | -46.58% | -0.42% | 159.08% |
| Total Debt Repaid | -2,399.84% | -- | -- | -- | 200.00% |
| Issuance of Common Stock | 4.95% | 4.95% | -- | 854.40% | -67.39% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 39.87% | 39.87% | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | 100.00% |
| Total Dividends Paid | 0.00% | 89.95% | 94.52% | 98.11% | 97.90% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -48.88% | -57.76% | 50.84% | 236.81% | 4,263.21% |
| Foreign Exchange rate Adjustments | -80.96% | -87.62% | 519.90% | 236.27% | 221.66% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 215.89% | 20.93% | 100.69% | 101.88% | 97.76% |
